PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
17-Jun-2024 Diabetic Retinopathy Market Poised for US$15.5 Billion Boom by 2033, Driven by Rising Diabetes Rates MARKITWIRED
17-Jun-2024 Epinephrine Auto-Injectors Market Set for Lifesaving Growth at 4.9% CAGR, Reaching US$3.2 Billion by 2032 | FMI Study MARKITWIRED
17-Jun-2024 Antidiabetics Market Set to Explode, Reaching US$223 Billion by 2032 Driven by Rising Diabetes Rates MARKITWIRED
17-Jun-2024 Clinical Chemistry Analyzers Market Gears Up for 4.8% CAGR, Reaching US$21.7 Billion by 2032 | FMI Study Report MARKITWIRED
17-Jun-2024 Emergency Medical Services Market Gears Up for Steady Growth, Reaching US$41.66 Billion by 2034 | FMI Report MARKITWIRED
17-Jun-2024 Varicella Vaccines Market Poised for Steady Growth, Reaching US$5.76 Billion by 2032 at a 6.3% CAGR | FMI Study Report MARKITWIRED
17-Jun-2024 Veterinary Services Market Booming at 8.4% CAGR, Set to Reach US$ 244.4 Billion by 2032 | FMI Analysis MARKITWIRED
17-Jun-2024 Dental Plaster Market Poised for Steady Growth, Reaching US$238.6 Million by 2032 at a 5.4% CAGR | FMI Study MARKITWIRED
17-Jun-2024 Creation of Spur Therapeutics Syncona Limited
17-Jun-2024 EHA 2024: Systemic mastocytosis (SM) patients in Europe face up to five years to obtain a diagnosis Blueprint Medicines
17-Jun-2024 Tony Kouzarides, Founder of STORM Therapeutics, Awarded British Knighthood for Services to Healthcare Innovation and Delivery STORM Therapeutics
17-Jun-2024 Frontier Science Scotland Strengthens Board of Trustees with New Appointment Frontier Science Scotland (FSS),
17-Jun-2024 NEW DATA PRESENTED AT EHA 2024 SHOW THE POTENTIAL OF CALQUENCE (ACALABRUTINIB) COMBINATION THERAPY TO PROVIDE DURABLE AND PROLONGED PROGRESSION-FREE SURVIVAL IN PATIENTS WITH MANTLE CELL LYMPHOMA AstraZeneca
17-Jun-2024 HUTCHMED Highlights Publication of Phase III ESLIM-01 Results in The Lancet Haematology HUTCHMED
17-Jun-2024 The last day for trading in Moberg Pharma's warrants of series 2023:1 (TO 2) is today, June 17th, 2024 Moberg Pharma
17-Jun-2024 TALVEY®▼ (talquetamab) demonstrated highly durable, longer-term responses in patients with relapsed or refractory multiple myeloma Johnson & Johnson
17-Jun-2024 Updated Phase 2 CAPTIVATE study results demonstrate sustained clinical benefit of fixed-duration IMBRUVICA® (ibrutinib) plus venetoclax as first-line treatment for patients with chronic lymphocytic leukaemia, including those with high-risk disease Johnson & Johnson
17-Jun-2024 How disposable vapes have become a prominent part of young people’s lives University of East Anglia
17-Jun-2024 Milestone for Biotest: US approval for innovative immunoglobulin Yimmugo Biotest AG
17-Jun-2024 Lynred showcases Seegnus, its first compact SXGA ‘HOT’ infrared sensor for tactical vision systems, at Eurosatory Andrew Lloyd Associates